Vimarsana
Biggest News Aggregation in the World

Page 46 - Biocon Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Ltd Today - Breaking & Trending Today

Biocon Biologics announces major leadership changes | Indiablooms - First Portal on Digital News Management - Vimarsana News

Biocon Biologics announces major leadership changes | Indiablooms - First Portal on Digital News Management

Mumbai: Biocon Biologics Ltd made leadership changes on Friday, revealing the appointments of Rhonda Duffy as Chief Operating Officer (COO) and Sandeep Athalye as Chief Development Officer.

Oligonucleotide Synthesis Market size to grow by USD 2,870.69 million from 2022 to 2027|Increasing research activities in the pharmaceutical and biotechnology sectors drive the market - Vimarsana News

Oligonucleotide Synthesis Market size to grow by USD 2,870.69 million from 2022 to 2027|Increasing research activities in the pharmaceutical and biotechnology sectors drive the market

/PRNewswire/ -- The oligonucleotide synthesis market size is estimated to increase by USD 2,870.69 million from 2022 to 2027. The market's growth momentum will...

Insulin Pump Market Size to Reach USD 11.4 Billion By 2032 - Vimarsana News

Insulin Pump Market Size to Reach USD 11.4 Billion By 2032

Acumen Research and Consulting recently published report titled “Insulin Pump Market Forecast, 2023 - 2032”...

Insulin Pump Market Size to Reach USD 11.4 Billion By 2032 According to Acumen Research and Consulting - Vimarsana News

Insulin Pump Market Size to Reach USD 11.4 Billion By 2032 According to Acumen Research and Consulting

Insulin Pump Market Size to Reach USD 11.4 Billion By 2032 According to Acumen Research and Consulting

Advent may rope in new investor for Bharat Serums with neat valuation markup - Vimarsana News

Advent may rope in new investor for Bharat Serums with neat valuation markup

Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a minority stake in the company, ......